Caldwell Sutter Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
6,035
+72
| +1% | +$13.4K | 0.51% | 47 |
|
|
2025
Q1 | $1.25M | Sell |
5,963
-227
| -4% | -$47.6K | 0.59% | 42 |
|
|
2024
Q4 | $1.1M | Buy |
6,190
+649
| +12% | +$115K | 0.51% | 51 |
|
|
2024
Q3 | $1.09M | Sell |
5,541
-201
| -4% | -$39.7K | 0.51% | 50 |
|
|
2024
Q2 | $985K | Sell |
5,742
-105
| -2% | -$18K | 0.49% | 53 |
|
|
2024
Q1 | $1.06M | Sell |
5,847
-344
| -6% | -$62.6K | 0.51% | 56 |
|
|
2023
Q4 | $959K | Sell |
6,191
-114
| -2% | -$17.7K | 0.49% | 59 |
|
|
2023
Q3 | $940K | Buy |
6,305
+38
| +0.6% | +$5.67K | 0.52% | 53 |
|
|
2023
Q2 | $844K | Buy |
6,267
+2,499
| +66% | +$337K | 0.44% | 66 |
|
|
2023
Q1 | $601K | Buy |
3,768
+1,988
| +112% | +$317K | 0.44% | 58 |
|
|
2022
Q4 | $288K | Buy |
+1,780
| New | +$288K | 0.25% | 83 |
|